The company formed as a joint project between Scorpion Medical and Monet Medical to provide medical technologies that are anticipated to enhance physicians’ use of orthobiologic materials and surgical procedures for treating orthopedic conditions.
Biologic Therapies plans to use autologous biologic therapy, or the body’s own stem cells, to increase healing potential and improve surgical and non-surgical results. The treatments apply to injuries involving the knee, ankle, elbow and shoulder as well as regeneration of cartilage and bone.
Related Articles on Orthopedic and Spine Devices:
K2M Hires 3 New International Team Leaders
11 Spine Devices Receive FDA 510(k) Clearance in September
15 Orthopedic and Spine Device Company Executive Moves
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
